JPRN-jRCT1091220053已完成Unknown
Clinical Trial of Therapeutic Effect of Valproic Acid in Retinitis Pigmentosa - VARP study
Yasuhiko Hirami0 个研究点目标入组 30 人开始时间: 2010年11月22日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with Retinitis Pigmentosa with decreased visual acuity less than 0.7 and 0.1 or better in decimal visual acuity, and visual field less than 10 degrees by I-4 in Goldmann kinetic perimetry
排除标准
- •1) Patients with retinal degeneration secondary to ocular infection or inflammation
- •2) Patients with ocular disease other than Retinitis Pigmentosa
- •3) Patients with pregnancy or breast-feeding
- •4) Patients with abnormality in liver function or urea cycle
- •5) Patients with any drug allergy
- •6) Patients with bipolar disorder and suicide attempt
- •7) Patients using following drugs; carbapenem antibiotic, barbiturate, phenytoin, carbamazepine, ethosuximide, amitoripuchin, norutoripuchin, kuropazamu, lamotrigine, salicylic acid, benzodiazepines, warfarin, erythromycin, cimetidine, clonazepam
- •8) any other case that research physicians decided to be inappropriate for the study
研究者
相似试验
进行中（未招募）
不适用
Preclinical and clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of head and neckRecurrent and/or metastatic squamous cell carcinoma of head and neckMedDRA version: 17.0Level: PTClassification code 10067821Term: Head and neck cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-001523-69-ITIstituto Nazionale Tumori di Napoli - Fondazione G. Pascale39
已完成
不适用
Aripiprazole effect in the treatment of maniaBipolar Disorder type I.Bipolar affective disorderIRCT201510222166N2niversity of Social Welfare and Rehabilitation Sciences40
已完成
2 期
Efficacy and safety of valproic acid in patients with postviral olfactory dysfunctiopostviral olfactory dysfunctionJPRN-UMIN000019966Shiga university of Medical Science15
进行中（未招募）
不适用
A phase II study assessing the activity of valproate acid plus doxorubicin in refractory or recurrent malignant mesothelioma.This is a prospective phase II study investigating well-known antimetabolite (doxorubicin) and antiepileptic (valproate) drugs, in combination, for the treatment of refractory or recurrent malignant mesothelioma for which no active treatment is available in this indication.EUCTR2006-001443-63-BEEuropean Lung Cancer Working Party41
尚未招募
3 期
Ayurvedic management of Epilepsy in childreCTRI/2023/03/050961Dr Suryanarayana Mudadla